Table TDI-8. Primary use of stimulants of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (i) New clients by country and type of stimulant (%)

Country		Amphetamines	%	Ecstasy	%	Other stimulants	%	Total stimulants
Belgium	(1)	33	91.7	3	8.3	0	0.0	36
Bulgaria		26	96.3	0	0.0	1	3.7	27
Czech Republic		2492	99.5	10	0.4	2	0.1	2504
Denmark		203	87.9	28	12.1	0	0.0	231
Germany	(2)	:	:	:	:	:	:	:
Estonia		8	100.0	0	0.0	0	0.0	8
Ireland		27	28.4	67	70.5	1	1.1	95
Greece		2	15.4	3	23.1	8	61.5	13
Spain	(3)	277	62.7	137	31.0	28	6.3	442
France		23	31.9	49	68.1	0	0.0	72
Italy		110	37.3	86	29.2	99	33.6	295
Cyprus		0	0.0	0	0.0	0	0.0	0
Latvia		259	87.2	9	3.0	29	9.8	297
Lithuania	(2)	:	:	:	:	:	:	:
Luxembourg		0	0.0	0	0.0	0	0.0	0
Hungary		200	85.8	31	13.3	2	0.9	233
Malta		0	0.0	16	100.0	0	0.0	16
Netherlands		466	82.5	67	11.9	32	5.7	565
Austria		27	61.4	14	31.8	3	6.8	44
Poland	(3 ; 4)	0	0.0	0	0.0	0	0.0	0
Portugal		1	8.3	10	83.3	1	8.3	12
Romania		3	16.7	15	83.3	0	0.0	18
Slovenia		0	0.0	1	100.0	0	0.0	1
Slovakia		333	100.0	0	0.0	0	0.0	333
Finland		82	96.5	1	1.2	2	2.4	85
Sweden		312	98.1	5	1.6	1	0.3	318
United Kingdom		1976	74.8	556	21.1	109	4.1	2641
Croatia		34	44.7	10	13.2	32	42.1	76
Turkey		1	2.9	34	97.1	0	0.0	35
Norway		:	:	:	:	:	:	:
Total		6895	82.1%	1152	13.7%	350	4.2%	8397

Notes:

 All types of treatment centres as defined by TDI Protocol 2.0 are included. 

 Percentages are of clients in treatment for stimulants as primary drug 

 (1) Last data available refer to 2005. 

 (2) For Germany and Lithuania only the aggregated data for Stimulants Total is available Germany (1456), Lithuania (13).  

 (3) Last data available refer to 2007.  

 (4) No breakdown by drug available 

 See also ‘General notes for interpreting data’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2009 — Standard table 3. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)